BNB PLUS CORP. BNBX
Nasdaq · XNAS · stock · Services-Testing Laboratories
Chart by TradingView
2/9
Piotroski F — financial health
-302.37
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.1M | -$15.2M | $838,907 | -$12.6M | $1.9M |
| 2024 | $2.1M | -$7.0M | $974,840 | -$14.0M | $9.0M |
| 2023 | $13.4M | -$9.9M | $5.5M | -$6.3M | $4.9M |
| 2022 | $18.2M | -$8.3M | $5.1M | -$9.5M | $12.9M |
| 2021 | $9.0M | -$14.3M | $4.5M | -$15.9M | $11.1M |
| 2020 | $1.9M | -$13.0M | — | -$12.2M | $5.7M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Ceccoli Joseph D. | director | 2025-10-17 | Grant | 22,511 | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -302.37 (distress)
- Working capital / assets -0.051
- Retained earnings / assets -85.446
- EBIT / assets -3.616
- Equity / liabilities 0.778
Source: SEC EDGAR filings · CIK 0000744452 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.